Revenue segments as reported by the company.

Life Sciences and Applied Markets Group

Diagnostics and Genomics Group

Agilent CrossLab Group

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Selling, general and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Agilent Technologies

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Agilent Technologies posts strong Q1 earnings, eyes PFAS testing and CRISPR expansion

Agilent Technologies delivered robust Q1 results, raised full-year guidance, and remains confident in its growth drivers. Despite challenges in the genomics market and uncertainties ahead, the company is strategically positioned to capitalize on opportunities and drive continued success.

Agilent reports strong Q2 earnings but revises down second-half forecast

Agilent Technologies delivered strong Q2 results but revised down second-half forecasts due to economic uncertainties. The company remains focused on driving margin expansion, cost efficiencies, and customer service excellence. Challenges from macroeconomic factors and market dynamics are being addressed with a strategic outlook for long-term growth.

Agilent Technologies faces China revenue challenges but eyes growth opportunities

Agilent Technologies faces revenue challenges in China but sees growth opportunities in companion diagnostics and liquid biopsy markets. The company remains confident in its ability to drive earnings growth despite recent setbacks.

Agilent reports mixed Q4 results, eyes steady recovery in 2024

Agilent Technologies reported mixed Q4 results with revenue decline but exceeded EPS guidance. While facing challenges in China and certain segments, the company anticipates slow but steady recovery for FY 2024. Agilent is focusing on cost-saving measures, pricing trends, and investments in growth areas like genomics and environmental solutions.

Agilent reports Q1 revenue decline, eyes global growth opportunities

Agilent Technologies' Q1 performance showed revenue decline but with strengths in certain segments like ACG and consumables. Challenges include revenue declines in DGG and LSAG impacting margins. Opportunities lie in global growth prospects and potential market surprises.

Agilent Technologies faces revenue decline but eyes growth opportunities ahead

Agilent Technologies navigated a challenging market in Q2 2024 with revenue declines across all end markets. The company remains focused on customer-centric strategies, cost optimization, and growth investments while addressing visibility challenges and exploring opportunities in high-growth segments.

Agilent reports Q3 earnings beat, eyes growth through acquisitions

Agilent Technologies delivered a solid performance in Q3 2024, exceeding earnings per share guidance and raising revenue and EPS midpoint guidance.
While facing revenue decline, the company's strategic investments and acquisitions signal a focus on growth and innovation.
Challenges include market dynamics and integration risks, but opportunities exist in leveraging digital initiatives and financial strength for future growth.

Agilent Technologies reports robust Q4 performance and outlines growth strategies

Agilent Technologies' Q4 2024 earnings call highlighted strong financial performance, strategic acquisitions, and a focus on margin expansion for sustainable growth.
Despite regional challenges and market uncertainties, the company remains optimistic about future prospects and is committed to driving EPS growth.
With a new market-focused approach and ongoing transformation initiatives, Agilent is well-positioned to capitalize on opportunities and navigate potential challenges in FY 2025.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CME Group

Intelsat

Friday's Silly Rally

CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis–Mass Spectrometry Solutions

Arista Networks

Keysight

Perion Network

It's time we started studying the sector because valuations are running low.

4 Under-the-Radar Tech Stocks Looking Good Right Now

Agilent Opens Center of Excellence for Dissolution Products

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the World Economic Forum's Global Lighthouse Network has named Agilent's facility in Singapore a Fourth Industrial Revolution (4IR) leader for effectively deploying innovative technologies at scale in the manufacture of scientific instruments. “Because of the incredible work of our team in Singapore, Agilent is among the leading manufacturers in our sector,” said Mike McMullen, president and CEO of Agilent

World Economic Forum Recognizes Agilent Facility in Singapore as a Leader in Advanced Manufacturing

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of its enhanced 8700 LDIR Chemical Imaging System, which has been further optimized for the analysis of microplastics in environmental samples. This newly improved package includes Clarity 1.5 software – a significant upgrade that advances the speed of analysis, enhances spectral acquisition, transformation, and library matching, and provides automated workflows for direct analysis of microplas

Agilent Announces Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is launching a partnership with Delaware State University (DSU), a leading historically Black university, to increase the share of underrepresented students entering STEM fields, a central mission of the company's philanthropic work through the Agilent Foundation. Agilent will donate $1 million in addition to new lab instrumentation to help DSU expand educational opportunities and advance research in applied chemistry, bi

Agilent Launches Partnership with Delaware State University to Advance Diversity in Science, Technology, Engineering and Math (STEM) Fields

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 21 cents per share of common stock will be paid on October 26, 2022, to all shareholders of record as of the close of business on October 4, 2022. The timing and amounts of future dividends are subject to determination and approval by Agilent's board of directors. Forward-Looking Statements This news release contains forward-looking statements as defined in the Securities Exchange A

Agilent Announces Cash Dividend of 21 Cents Per Share

Agilent (A) reported earnings 30 days ago. What's next for the stock?

Agilent (A) Down 6.4% Since Last Earnings Report: Can It Rebound?

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #GreatPlacetoWork--Agilent Technologies Inc. (NYSE: A) today announced the company has achieved Great Place to Work® Certification™ in 20 countries and regions, a recognition that distinguishes Agilent as a top employer based on an independent survey of its global workforce. The 20 certified countries and regions are Australia, Belgium, Brazil, Canada, China, Denmark, France, India, Ireland, Italy, Korea, Malaysia, Mexico, the Netherlands, Spain, Sweden, Taiwan, Thailand, the

Agilent Earns Great Place to Work® Certification in 20 Countries and Regions

Agilent reached the price target I suggested in April and is now showing even more strength. The stock is a leader in its industry and the healthcare sector is among the strongest in 3 months.

Agilent Confirmed Its Leadership And Is Set For Further Gains (Technical Analysis)

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced Christoph Herwig has been selected to receive a prestigious Agilent Thought Leader Award. A prominent researcher in the field of bioprocess technology, Christoph Herwig is a Professor of Biochemical Engineering at TU Wien, Vienna, Austria. Prof. Herwig's work focuses on developing end-to-end scientific workflows in bioprocess technology. His interdisciplinary approach aims to generate a holistic process co

Agilent Announces Thought Leader Award to Professor Christoph Herwig

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #GreatPlacetoWork--Agilent Technologies Inc. (NYSE: A) today announced that the company has been named a “Best Workplace in Health Care” in the United States by Fortune magazine. Agilent's number 17 ranking is based on the Great Place to Work® employee survey and company-provided data. Eighty-five percent of Agilent employees who responded to the survey indicated that the company is a great place to work, compared to 57 percent of employees at a typical U.S.-based company, re

Fortune Ranks Agilent Among Top Workplaces in Health Care

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has received an award for leadership in advancing environmental sustainability from the Business Intelligence Group. The award recognizes Agilent's sustainability efforts across all its operations and through all its products and services, which are used in more than 265,000 labs worldwide. The Sustainability Awards recognize organizations that have made sustainability an integral part of their business practice or overal

Agilent Receives Award for Sustainability Leadership

Agilent (A) collaborates with Mettler Toledo to lessen errors during sample preparation for achieving better chromatographic results.

Agilent (A) to Penetrate Chromatography Market Via New Tie-Up

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it is collaborating with METTLER TOLEDO to address one of the biggest concerns in any laboratory—error-prone sample preparation. This integrated solution allows the automatic and seamless transfer of weighing results and the associated metadata from METTLER TOLEDO LabX™ Balance software to Agilent OpenLab software. Sample preparation is a critical part of many laboratory workflows. It is a time-consum

Agilent Collaborates with METTLER TOLEDO to Reduce Errors in Sample Preparation Workflows for Better Chromatographic Results

Investors need to pay close attention to Agilent Technologies (A) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Agilent Technologies (A) Stock?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Agilent Technologies (A) is a Strong Growth Stock

HUYA Inc - ADR

Weber

Investors were running for cover on Friday, as markets were pulling back yet again.

Why Citigroup Pumped the Brakes on These 3 Stocks After Earnings

Agilent's (A) results for the fiscal third quarter reflect strong momentum in the pharma, and chemical & energy market.

Agilent (A) Q3 Earnings Surpass Estimates, Revenues Rise Y/Y

Illumina

Agilent Technologies proved its worth in FQ3 and was able to raise guidance as well, sending its shares higher as it continues to outperform Illumina.

Agilent Technologies Proves Its Worth VS Illumina

Agilent stock jumped Wednesday after putting together a strong quarterly beat that ignored the messy Covid dynamics plaguing other medtech companies. The post Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics appeared first on Investor's Business Daily.

Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics

BOSTON--(BUSINESS WIRE)--Mytide Therapeutics, a company transforming peptide manufacturing with predictive analytics and machine learning, has partnered with Agilent, a global leader in life science, diagnostic and applied chemical markets. The two companies will collaborate on robust, scalable and reliable automation solutions for Mytide's BioFab2 platform, a technology suite that combines chemistry, robotics and machine learning to advance and accelerate peptide and peptide conjugate manufact

Mytide Therapeutics Partners with Agilent to Collaborate on Automation Solutions for Mytide's Next-generation Manufacturing Platform

Agilent Technologies, Inc. (NYSE:A ) Q3 2022 Earnings Conference Call August 16, 2022 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Mike McMullen - President and Chief Executive Officer Bob McMahon - Senior Vice President and Chief Financial Officer Jacob Thaysen - President, Agilent Life Science and Applied Markets Group Sam Raha - President, Agilent Diagnostics and Genomics Group Padraig McDonnell - President, Agilent CrossLab Group Conference Call Participants Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Vijay Kumar - Evercore ISI Puneet Souda - SVB Rachel Vatnsdal - JPMorgan Mike Ryskin - Bank of America Josh Waldman - Cleveland Research Jack Meehan - Nephron Research Elizabeth Garcia - UBS Patrick Donnelly - Citi Tim Daley - Wells Fargo Operator Good afternoon. Thank you for attending today's Agilent Technologies Q3 ‘22 Earnings Call.

Agilent Technologies, Inc. (A) CEO Mike McMullen on Q3 2022 Results - Earnings Call Transcript

Shares of Agilent Technologies Inc. A, -0.84% rose more than 5% in the extended session Tuesday after the maker of lab instruments and other components reported fiscal third-quarter results above Wall Street expectations and raised guidance for the year. Agilent said it earned $329 million, or $1.10 a share, in the quarter, compared with $264 million, or 86 cents a share, in the year-ago period.

News for Agilent Technologies Stock (A)